12.34
0.03 (0.24%)
0.03 (0.24%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.03 | 0.24% | 12.34 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.18 | 11.97 | 12.355 | 12.34 | 12.31 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 11.50 | 13.40 | 1.90 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,451 | 422,008 | $ 12.18 | $ 5,141,684 | 704,741 | 7.58 - 15.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:04:14 | average | 978 | $ 12.305 | USD |
Innoviva Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.25B | 101.39M | 57.64M | $ 261.02M | $ 231.86M | 1.43 | 6.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Innoviva News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.83 | 13.03 | 11.97 | 12.59 | 574,056 | -0.49 | -3.82% |
| 1 Month | 12.52 | 13.06 | 11.97 | 12.52 | 519,100 | -0.18 | -1.44% |
| 3 Months | 10.64 | 13.06 | 10.10 | 11.46 | 664,667 | 1.70 | 15.98% |
| 6 Months | 13.94 | 14.18 | 9.21 | 11.53 | 707,399 | -1.60 | -11.48% |
| 1 Year | 14.50 | 15.69 | 7.58 | 12.41 | 739,664 | -2.16 | -14.9% |
| 3 Years | 14.81 | 20.54 | 7.58 | 14.07 | 793,386 | -2.47 | -16.68% |
| 5 Years | 9.66 | 20.54 | 7.58 | 13.34 | 798,887 | 2.68 | 27.74% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline. |
